白细胞介素在人脑胶质瘤基因免疫治疗中的研究
被引量:2
出处
《中华神经外科疾病研究杂志》
CAS
2009年第5期385-388,共4页
Chinese Journal of Neurosurgical Disease Research
基金
国家自然科学基金资助项目(30872645)
山东省自然科学基金资助项目(Y2008C57)
参考文献22
-
1Ohgaki H. Epidemiology of Brain Tumors [ J ]. Methods Mol Biol,2009, 472:323 - 342. 被引量:1
-
2Bryan L, Paugh BS, Kapitonov D, et al. Sphingosine-1-phosphate and interleukin-1 inde- pendently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness [J]. Mol Cancer Res, 2008, 6(9) : 1469 -1477. 被引量:1
-
3Gu J, Li G, Sun T, et al. Blockage of the STA33 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells [ J]. J Neurooncol, 2008, 89( 1 ) : 9 - 17. 被引量:1
-
4Lam LT, Wright G, Davis RE, et al. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-κB pathways in subtypes of diffuse large B-cell lymphoma [ J ]. Blood, 2008, 111(7) : 3701 -3713. 被引量:1
-
5Shouda T, Hiraoka K, Komiya S, et al. Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells [J]. Cancer Lett, 2006, 231 (2) : 176 - 184. 被引量:1
-
6Leu CM, Wong FH, Chang C, et al. Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways [J]. Oncogene, 2003, 22(49): 7809-7818. 被引量:1
-
7Chen RH, Chang MC, Su YH, et al. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription-3 pathways [ J]. J Biol Chem, 1999, 274(33) : 23013 -23019. 被引量:1
-
8Loeffler S, Fayard B, Weis J, et al. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1[ J]. Int J Cancer, 2005, 115(2): 202-213. 被引量:1
-
9de la Iglesia N, Konopka G, Lim KL, et al. Deregulation of a STAT3- interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness [ J]. J Neurosci, 2008, 28 (23): 5870 - 5878. 被引量:1
-
10Kioi M, Husain SR, Croteau D, et al. Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy [ J ]. Technol Cancer Res Treat, 2006, 5 (3) : 239 - 250. 被引量:1
同被引文献20
-
1Yang L,Anderson DE,Baecher-AUan C,et al.IL-21 and TGF-beta are required for differentiation of human T(H) 17 cells.Nature,2008,454:350-352. 被引量:1
-
2Chen X,Wan J,Liu J,et al.Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients.Lung Cancer,69:348-354. 被引量:1
-
3Munn DH.Thl7 cells in ovarian cancer.Blood,2009,114:1134-1135. 被引量:1
-
4Zhang YL,Li J,Mo HY,et al.Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways.Mol Cancer,2010,9:4. 被引量:1
-
5Wang L,Yi T,Kortylewski M,et al.IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway.J Exp Med,2009,206:1457-1464. 被引量:1
-
6Chang YH,Yu CW,Lai LC,et al.Up-regulation of interleukin-17 expression by human papillomavirus type 16 E6 in nonsmall cell lung cancer.Cancer,2010,116:48004809. 被引量:1
-
7Numasaki M,Watanabe M,Suzuki T,et al.IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis.J Immunol,2005,175:6177-6189. 被引量:1
-
8Bruna A,Darken RS,Rojo F,et al.High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDCF-B gene.Cancer Cell,2007,11:147-160. 被引量:1
-
9Ivanov II,McKenzie BS,Zhou L,et al.The orphan nuclear receptor ROR gamma directs the differentiation program of proinflammatory IL-17+ T helper cells.Cell,2006,126:1121-1133. 被引量:1
-
10Zhang JF,Yan J,Xu J,et al.Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.J Hepatol,2009,50:980-989. 被引量:1
二级引证文献8
-
1郑鲲鹏,宋辉,樊明德,张源,李科,王成伟.Th17细胞相关因子在人脑胶质瘤中的测定[J].山东大学学报(医学版),2012,50(6):87-91. 被引量:5
-
2张洪涛 修春明 牛洪泉,王云波 汤国太.环氧化酶2抑制剂塞来昔布对胶质瘤树突状细胞表型和功能的影响[J].中华行为医学与脑科学杂志,2012,21(10):880-883. 被引量:3
-
3蒋伟峰,刘窗溪,高方友.白细胞介素-17及其受体在脑胶质瘤中的表达研究进展[J].临床神经外科杂志,2014,11(2):156-158. 被引量:5
-
4王宏宇,马玉美,崔建忠,赵迪,刘爱军,洪军,卢永刚,王凯杰.可溶性血管内皮钙粘素与脑胶质瘤患者生存期相关性研究[J].中华行为医学与脑科学杂志,2015,24(6):536-539. 被引量:3
-
5郭高飞,王仁芳,张伟.甘草酸对胶质瘤患者血清PDGF、IL-17、MCP-1及SRF血清反应因子的影响研究[J].中国生化药物杂志,2015,35(9):94-96. 被引量:2
-
6王彬,韩志强,侯立军.IL-1家族在神经胶质瘤研究中的作用和意义研究进展[J].中国临床研究,2016,29(3):413-416. 被引量:5
-
7梁阿铭,吕国伟,韩义娜.甘草酸对胶质瘤患者血清血小板衍生生长因子(PDGF)、白细胞介素17(IL-17)、单核细胞趋化蛋白-1(MCP-1)及血清反应因子SRF的影响[J].中药药理与临床,2016,32(1):163-166. 被引量:8
-
8曹阳,戴金应,李论,臧培卓.异甘草素对大鼠脑胶质瘤MCP-1和IL-17表达的影响[J].解剖科学进展,2016,22(6):610-613. 被引量:1
-
1陈坛輈,黄智铭,周丽萍.肝细胞癌的基因免疫治疗[J].温州医学院学报,2005,35(4):342-343.
-
2何天霖,傅传刚.结直肠癌术后癌胚抗原基因疫苗辅助治疗的研究现状[J].中华胃肠外科杂志,2001,4(4):267-269. 被引量:4
-
3李靖,周建波,梁平.肝癌基因治疗研究最新进展[J].重庆医学,2005,34(11):1721-1724. 被引量:1
-
4赵旭飞,沈岩.胰腺癌的综合治疗进展[J].国际外科学杂志,2006,33(3):185-189. 被引量:9
-
5兰英华,李用国,任红.甲胎蛋白与肝细胞癌[J].国际肿瘤学杂志,2004,31(S1):90-93.
-
6李奇灵.TGFβ与妇科肿瘤[J].国外医学(妇幼保健分册),1998,9(1):23-26.
-
7叶敏,费哲为.胃癌的基因免疫治疗[J].实用医学杂志,2008,24(4):502-503. 被引量:1
-
8房良华,姜藻.肝癌的基因免疫治疗若干研究[J].东南大学学报(医学版),2005,24(5):351-354.
-
9孙永明,王海斌,胥正泉,田康松.白细胞介素-4修饰骨肉瘤SAOS-2细胞在SCID小鼠体内基因免疫治疗的研究[J].中华实验外科杂志,2009(9):1229-1229.
-
10王谨,李升平,郑利民.基因修饰T淋巴细胞在肿瘤免疫治疗中的应用[J].中国肿瘤生物治疗杂志,2008,15(3):292-295. 被引量:2